CIT and prostate carcinoma: This study further demonstrates the applicability of lentiviral based shRNA for conducting phenotypic screens to identify targets involved in a variety of biological processes, and establishes MAP3K11, DGKD, ICK, CIT, GALK2, and PSKH1 as regulators of prostate cancer cell growth.